Trials / Recruiting
RecruitingNCT07048496
Intravesical Treatment of Bladder Cancer at Home, Multi-modal Treatment Support
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- Sponsor
- University of Pennsylvania · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.
Detailed description
The proposed project will have two separate cohorts. The first will be to perform a more in-depth qualitative assessment of the barriers and facilitators for treatment compliance for non-muscle invasive bladder cancer. The second arm will be to create and test a BCG at home program. Participants in the second cohort will be enrolled in a conversational agent to measure patient symptoms and quality of life and improve self-efficacy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | BCG delivery at home | The BCG at home project will be a single-arm prospective pilot, to evaluate the feasibility, scalability and effectiveness of home treatment, and utilize the BB-Bot (chatbot) for PRO and adverse event measurement. |
Timeline
- Start date
- 2025-07-05
- Primary completion
- 2026-08-05
- Completion
- 2026-09-05
- First posted
- 2025-07-02
- Last updated
- 2025-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT07048496. Inclusion in this directory is not an endorsement.